Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis

Effects of inflammatory and anti-inflammatory cytokines on the bone

(2011) Georg Schett   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

A role for interleukin-33 in TH2-polarized intestinal inflammation?

(2011) J B Seidelin et al.   Mucosal Immunology

Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation

(2011) Luca Pastorelli et al.   Therapeutic Advances in Gastroenterology

Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes

(2010) Se Hwan Mun et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling

(2010) S. Saidi et al.   CYTOKINE

Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells

(2010) Jochen Schulze et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis

(2010) Ayako Kobori et al.   JOURNAL OF GASTROENTEROLOGY

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

(2010) Luca Pastorelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors?

(2010) Franco Scaldaferri   WORLD JOURNAL OF GASTROENTEROLOGY

IL-33 and IL-33 Receptors in Host Defense and Diseases

(2010) Keisuke Oboki et al.   ALLERGOLOGY INTERNATIONAL

Role of interleukin 33 in human immunopathology

(2009) G E J Murphy et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-33 is upregulated in colonocytes of ulcerative colitis

(2009) Jakob Benedict Seidelin et al.   IMMUNOLOGY LETTERS

Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease

(2009) Caroll J. Beltrán et al.   INFLAMMATORY BOWEL DISEASES

High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD

(2009) Alberto J. León et al.   MEDIATORS OF INFLAMMATION

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis

(2008) S. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gut, inflammation and osteoporosis: basic and clinical concepts

(2008) H. Tilg et al.   GUT

Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease

(2008) Reikei Matsuda et al.   INFLAMMATORY BOWEL DISEASES

Osteoporosis in inflammatory bowel disease

(2008) Max Reinshagen   Journal of Crohns & Colitis